Latest News about PGEN
Recent news which mentions PGEN
From Benzinga
From Benzinga
Earnings Scheduled For May 13, 2026
May 13, 2026
From Benzinga
SelectQuote Posts Better-Than-Expected Results, Joins Nutex Health, NIO, MINISO Group And Other Big Stocks Moving Higher On Thursday
August 21, 2025
From Benzinga
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday
August 19, 2025
From Benzinga
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
August 19, 2025
From Benzinga
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 19, 2025
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 15, 2025
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 15, 2025
From Benzinga
Crude Oil Down 1%; US Retail Sales Rise 0.5% In July
August 15, 2025
From Benzinga
From Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday
August 15, 2025
From Benzinga
Why Is Precigen Stock Surging On Friday?
August 15, 2025
From Benzinga
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
August 15, 2025
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 15, 2025
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 16, 2025
From Benzinga
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
July 09, 2025
From Benzinga
From Benzinga
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday
March 21, 2025
From Benzinga
Earnings Scheduled For March 19, 2025
March 19, 2025
From Benzinga
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday
January 23, 2025
From Benzinga
Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment
December 30, 2024
From Benzinga